Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding

Mol Endocrinol. 1989 Jul;3(7):1061-9. doi: 10.1210/mend-3-7-1061.

Abstract

Hormone binding controls the activity of estradiol receptor. The in vitro synthesized human receptor binds hormone with high affinity and low efficiency (1-4% of the maximal binding). We now report that phosphorylation on tyrosine of the synthetic receptor by an extensively purified calf uterus kinase increases hormone binding towards maximal levels without change in affinity. This is the first direct demonstration that a newly synthesized hormone receptor acquires ligand binding through phosphorylation. The use of in vitro synthesized proteins as substrates for enzymes which cause functional modifications of proteins is very promising because it is easy to identify the modified domains and residues by using deleted and point mutated proteins. Experiments with two estradiol receptor deletion mutants, one which lacks the N-terminal half of the receptor and binds hormone independently from the N-terminal half of the receptor, the other which lacks the C-terminal half of the receptor and contains the domain required to recognize the estradiol responsive elements, show that tyrosine phosphorylation occurs exclusively within or near the hormone binding domain of the receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / analysis
  • Animals
  • Binding, Competitive
  • Cattle
  • Electrophoresis, Polyacrylamide Gel
  • Estradiol / metabolism
  • Female
  • Phosphorylation
  • Precipitin Tests
  • Protein-Tyrosine Kinases / physiology*
  • Receptors, Estrogen / genetics
  • Receptors, Estrogen / metabolism*
  • Sodium Dodecyl Sulfate
  • Uterus / metabolism

Substances

  • Amino Acids
  • Receptors, Estrogen
  • Sodium Dodecyl Sulfate
  • Estradiol
  • Protein-Tyrosine Kinases